Nutex Health (NASDAQ:NUTX) Earns Buy Rating from Analysts at B. Riley Financial

B. Riley Financial initiated coverage on shares of Nutex Health (NASDAQ:NUTX) in a report issued on Friday. The firm set a “buy” rating and a $290.00 price target on the stock. B. Riley Financial’s target price would suggest a potential upside of 94.50% from the company’s previous close.

NUTX has been the topic of a number of other reports. Lake Street Capital started coverage on Nutex Health in a research report on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price objective on the stock. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, May 4th. Finally, Wall Street Zen upgraded Nutex Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $243.33.

Nutex Health Trading Up 1.1%

NUTX opened at $149.10 on Friday. Nutex Health has a 1-year low of $77.21 and a 1-year high of $193.07. The stock has a market capitalization of $1.03 billion, a PE ratio of 11.52 and a beta of 0.26. The company has a current ratio of 3.14, a quick ratio of 3.12 and a debt-to-equity ratio of 0.66. The firm has a 50-day moving average price of $128.09 and a two-hundred day moving average price of $130.09.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings results on Thursday, April 30th. The company reported $6.52 EPS for the quarter, beating the consensus estimate of $3.99 by $2.53. The business had revenue of $216.49 million for the quarter, compared to analysts’ expectations of $227.80 million. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%.

Institutional Investors Weigh In On Nutex Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NUTX. Topline Capital Management LLC boosted its holdings in Nutex Health by 80.0% during the third quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock worth $57,505,000 after buying an additional 247,436 shares during the last quarter. Pertento Partners LLP raised its position in shares of Nutex Health by 20.0% in the 4th quarter. Pertento Partners LLP now owns 324,422 shares of the company’s stock valued at $53,406,000 after acquiring an additional 54,001 shares during the period. Vanguard Group Inc. boosted its stake in Nutex Health by 12.7% during the 3rd quarter. Vanguard Group Inc. now owns 214,954 shares of the company’s stock worth $22,209,000 after acquiring an additional 24,275 shares during the last quarter. Millennium Management LLC boosted its stake in Nutex Health by 191.1% during the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock worth $9,650,000 after acquiring an additional 61,308 shares during the last quarter. Finally, State Street Corp grew its holdings in Nutex Health by 11.6% during the fourth quarter. State Street Corp now owns 86,792 shares of the company’s stock valued at $14,288,000 after purchasing an additional 9,052 shares during the period. Institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight?loss services and behavioral health support. By combining in?person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost?effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail?anchored centers, offering treatment for non?life?threatening injuries and illnesses, preventive screenings and basic primary care.